A new COVID-19 variant called “Cicada” is spreading. Here’s what to know.

The emergence of the BA.3.2 variant of COVID-19, nicknamed “Cicada,” has garnered attention from health authorities such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). This variant, first identified in November 2024, has now spread to at least 23 countries and 25 states in the U.S. as of February. Although it is spreading, BA.3.2 is not yet the dominant strain, and its potential impact remains to be seen.

BA.3.2 belongs to the Omicron family and is characterized by a high number of mutations, with 70 to 75 mutations. A recent study published in the Lancet revealed that the current COVID-19 vaccine may be less effective against BA.3.2 compared to other dominant strains, although it still provides some level of protection. Dr. William Schaffner, an infectious disease expert from Vanderbilt University, emphasized the need for continued monitoring of the variant’s ability to evade existing protections.

Despite the presence of the Cicada variant, nationwide data from the CDC does not indicate a significant increase in severe COVID-19 cases. While case rates and hospitalizations are declining overall, certain states like Massachusetts and Florida are experiencing potential increases in cases. Dr. Celine Gounder, a medical contributor for CBS News, reassured that there is no evidence suggesting that the variant causes more severe disease or higher hospitalization rates.

Common symptoms of COVID-19 include fever, cough, shortness of breath, sore throat, and congestion. The CDC recommends that individuals aged 65 and older, those who have not yet been vaccinated, or individuals at high risk for severe illness receive the current COVID vaccine. This high-risk group includes individuals under 65 with underlying medical conditions or compromised immune systems. Dr. Schaffner also advised getting vaccinated towards the end of May or beginning of June to prepare for any potential increase in cases during the summer.

In conclusion, the presence of the Cicada variant underscores the importance of ongoing vigilance and vaccination efforts to combat the evolving landscape of COVID-19. By staying informed, following public health guidelines, and prioritizing vaccination, individuals can help mitigate the spread of the variant and protect themselves and others from the virus.

This article was edited by Paula Cohen and provides valuable insights into the current status of the Cicada variant and its implications for public health.